Timothy Yap
MBBS, PhD
Professor, Department of Investigational Cancer Therapeutics
👥Biography 个人简介
Timothy Yap is a phase 1 immunotherapy trialist at MD Anderson who leads trials of engineered cytokines including IL-2 variants, IL-15 superagonists, and novel cytokine combinations in solid tumors. He also leads DDR and immunotherapy combination studies. His work helps define the next generation of cytokine-based cancer therapy.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Timothy Yap 的研究动态
Follow Timothy Yap's research updates
留下邮箱，当我们发布与 Timothy Yap（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment